Back
BridgeBio Pharma Stock Price Chart
Sponsored
BBIO
Sponsored
The AI Energy Miracle
Details Here.
Sell
39
BBIO
BridgeBio Pharma
Last Price:
$26.49
Seasonality Move:
-20.12%
7 Day Trial
ALL ACCESS PASS
$
7
How to Turn the AI Energy Crisis into BIG Profits
And investors who move now into one technology could make a whole lot of money.-
The current trend is moderately bearish and BBIO is experiencing slight buying pressure.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.3 | Sell |
20-day SMA: | 27.21 | Sell |
50-day SMA: | 25.73 | Buy |
200-day SMA: | 26.64 | Sell |
8-day EMA: | 27.01 | Sell |
20-day EMA: | 26.87 | Sell |
50-day EMA: | 26.24 | Buy |
200-day EMA: | 26.64 | Sell |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 49.08 | Sell |
Chaikin Money Flow: | 316290 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.3 - 28.44) | Buy |
Bollinger Bands (100): | (24.03 - 27.65) | Buy |
BridgeBio Pharma Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 26.50 while BBIO 8-day simple moving average is 27.30, which is a Sell signal.
-
The stock price of BBIO is 26.50 while BridgeBio Pharma 20-day SMA is 27.21, which makes it a Sell.
-
BridgeBio Pharma 50-day simple moving average is 25.73 while BBIO share price is 26.50, making it a Buy technically.
-
BBIO stock price is 26.50 and BridgeBio Pharma 200-day simple moving average is 26.64, creating a Sell signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
39
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a SellThe current BridgeBio Pharma [BBIO] share price is $26.50. The Score for BBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
5B
Price in USD:
26.50
Share Volume:
4M
BridgeBio Pharma 52-Week Range
52-Week High:
44.32
52-Week Low:
21.62
Sell
39
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?The BridgeBio Pharma stock price is 26.50 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 26.50 while BBIO 8-day exponential moving average is 27.01, which is a Sell signal.
-
The stock price of BBIO is 26.50 while BridgeBio Pharma 20-day EMA is 26.87, which makes it a Sell.
-
BridgeBio Pharma 50-day exponential moving average is 26.24 while BBIO share price is 26.50, making it a Buy technically.
-
BBIO stock price is 26.50 and BridgeBio Pharma 200-day simple moving average is 26.64, creating a Sell signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $1.07 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is 0.4, suggesting BridgeBio Pharma is a Buy
-
BridgeBio Pharma Relative Strength Index (RSI) is 49.08, which suggest BridgeBio Pharma is oversold
-
The Bollinger Bands (25) for BridgeBio Pharma is (24.3 - 28.44), which suggest BridgeBio Pharma is a Buy
-
The Bollinger Bands (100) for BridgeBio Pharma is (24.03 - 27.65), which suggest BridgeBio Pharma is a Buy
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.